- Home
- CALC vs SIF Comparison
CALC vs SIF Comparison
Compare CALC & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- SIF
- Stock Information
- Founded
- CALC 2011
- SIF 1913
- Country
- CALC United States
- SIF United States
- Employees
- CALC N/A
- SIF N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- SIF Office Equipment/Supplies/Services
- Sector
- CALC Health Care
- SIF Industrials
- Exchange
- CALC Nasdaq
- SIF Nasdaq
- Market Cap
- CALC 45.4M
- SIF 44.2M
- IPO Year
- CALC N/A
- SIF N/A
- Fundamental
- Price
- CALC $3.11
- SIF $7.28
- Analyst Decision
- CALC Strong Buy
- SIF
- Analyst Count
- CALC 2
- SIF 0
- Target Price
- CALC $14.50
- SIF N/A
- AVG Volume (30 Days)
- CALC 46.6K
- SIF 16.6K
- Earning Date
- CALC 11-12-2025
- SIF 08-14-2025
- Dividend Yield
- CALC N/A
- SIF N/A
- EPS Growth
- CALC N/A
- SIF N/A
- EPS
- CALC N/A
- SIF N/A
- Revenue
- CALC N/A
- SIF $83,663,000.00
- Revenue This Year
- CALC N/A
- SIF N/A
- Revenue Next Year
- CALC N/A
- SIF N/A
- P/E Ratio
- CALC N/A
- SIF N/A
- Revenue Growth
- CALC N/A
- SIF 35.71
- 52 Week Low
- CALC $1.42
- SIF $2.33
- 52 Week High
- CALC $5.65
- SIF $7.88
- Technical
- Relative Strength Index (RSI)
- CALC 48.87
- SIF 55.11
- Support Level
- CALC $3.04
- SIF $6.54
- Resistance Level
- CALC $3.15
- SIF $7.50
- Average True Range (ATR)
- CALC 0.18
- SIF 0.33
- MACD
- CALC -0.03
- SIF 0.01
- Stochastic Oscillator
- CALC 21.74
- SIF 77.08
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.